DDrare: Database of Drug Development for Rare Diseases

Parsaclisib (DrugBank: Parsaclisib)

3 diseases

ID	Disease name (Link within this page)	Number of trials
35	Pemphigus	1
53	Sjogren syndrome	1
61	Autoimmune hemolytic anemia	1

35. Pemphigus [ 87 clinical trials, 114 drugs, (DrugBank: 37 drugs), 17 drug target genes, 158 drug target pathways]

Searched query = "Pemphigus"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 87 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03780166 (ClinicalTrials.gov)	March 2019	17/12/2018	A Study of the Safety and Tolerability of INCB050465 in Pemphigus Vulgaris	A Phase 2 Dose-Escalation Study of the Safety and Tolerability of INCB050465 in Participants With Pemphigus Vulgaris	Pemphigus Vulgaris	Drug: Parsaclisib	Incyte Corporation	NULL	Withdrawn	18 Years	80 Years	All	0	Phase 2	NULL

53. Sjogren syndrome [ 234 clinical trials, 270 drugs, (DrugBank: 85 drugs), 49 drug target genes, 174 drug target pathways]

Searched query = "Sjogren syndrome", "Sjögren syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 234 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03627065 (ClinicalTrials.gov)	September 24, 2018	8/8/2018	A Study of INCB050465 in Primary Sjögren's Syndrome	An Open-Label Phase 2 Study of INCB050465 in Participants With Primary Sjögren's Syndrome	Primary Sjögren's Syndrome	Drug: Parsaclisib	Incyte Corporation	NULL	Completed	18 Years	N/A	All	10	Phase 2	United States

61. Autoimmune hemolytic anemia [ 90 clinical trials, 72 drugs, (DrugBank: 23 drugs), 19 drug target genes, 147 drug target pathways]

Searched query = "Autoimmune hemolytic anemia", "AIHA", "WAIHA", "Cold agglutinin disease", "CAD", "Paroxysmal cold hemoglobinuria", "MAIHA", "Evans syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 90 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03538041 (ClinicalTrials.gov)	November 21, 2018	15/5/2018	A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia	A Phase 2, Open-Label Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia	Autoimmune Hemolytic Anemia	Drug: Parsaclisib	Incyte Corporation	NULL	Recruiting	18 Years	N/A	All	25	Phase 2	United States;Austria;France;Italy